Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Estimated Cost-effectiveness of Genetic Testing in Siblings of Newborns With Cancer Susceptibility Gene Variants.

JAMA network open - 1 Oct 2021

O'Brien Grace, Christensen Kurt D, Sullivan Haley K, Stout Natasha K, Diller Lisa, Yeh Jennifer M, Wu Ann Chen

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cost-Benefit Analysis
Share to Genetic Predisposition to Disease
Share to Genetic Testing
Share to Infant, Newborn

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 34661666
DOI: 10.1001/jamanetworkopen.2021.29742
PMCID: PMC8524309

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Estimated Cost-effectiveness of Genetic Testing in Siblings of Newborns With Cancer Susceptibility Gene Variants.PMID 34661666Read ↗

Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping review.Semantic proximity Read ↗

Cancer genetics services: a systematic review of the economic evidence and issues.Semantic proximity Read ↗

Genetic testing and economic evaluations: a systematic review of the literature.Semantic proximity Read ↗

Economic impact of multigene panel testing for hereditary breast and ovarian cancer.Semantic proximity Read ↗

Summaries for patients. Comparing the benefits and costs of testing for genetic causes of colon cancer.Semantic proximity Read ↗

Quantifying the health benefits of genetic tests: the importance of a population perspective.Semantic proximity Read ↗

Predictive genetic tests and health system costs.Semantic proximity Read ↗

Economic evaluations of pharmacogenetic and genomic screening programs: update of the literature.Semantic proximity Read ↗

Can we really afford to spend NHS cash on genetic testing for cancer?Semantic proximity Read ↗

Protocol for a Prospective, Observational Cost-effectiveness Analysis of Returning Secondary Findings of Genome Sequencing for Unexplained Suspected Genetic Conditions.Semantic proximity Read ↗

Cost and effectiveness of the California triple marker prenatal screening programSemantic proximity Read ↗

Towards population-based genetic screenings for breast and ovarian cancer: A comprehensive review from economic evaluations to patient perspectives.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.